Knalysis Technologies is On the Move

Pickering, Ontario, CANADA


TORONTO, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Knalysis Technologies “Knalysis”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) would like you to get to know Knalysis better.


For those wishing to meet our team and see our industry leading software platforms in person, our sales team will be travelling to several conferences in the coming months.   On the international stage, the Knalysis team will be exhibiting at CannaTech in Tel Aviv, Israel, in March and here in North America we will be participating as an exhibitor and panelist at the World Medical Marijuana Conference in Pittsburgh in April, as we explore the different facets of technology in this industry. Focusing on conferences geared to the medical and research communities, Knalysis anticipates that these will yield critical partnerships and continue to drive our sales pipeline in key markets.

Our Team is Growing:

Keeping pace with the growth of the business, the Knalysis team is expanding!  We are currently adding ten new positions to our roster to focus on research and development of our platforms as well as sales and marketing.  These positions will reside in the US and Canada to support operations in both markets and report to our executive team. 

Meet the Knalysis Executive Team:

Paul Methot, President

With over 20 years in IT, Paul has garnered experience working for some of the largest names in the industry: Microsoft, IBM, CGI, RBC, RCMP, Bank of America, and more. His career has included an award-winning platform to track and capture pedophiles, now in use by 19 countries as the CSO of IT security firm, CyberSecure, which he and his partners sold in 2004. After co-founding GreenNexxus, which measured humanity’s environmental impact, they went on to win two awards working with Cisco Systems and CBC's George Stroumboulopoulos to launch the One Million Acts of Green campaign and also working with Al Gore and his organization, The Climate Project. 

In recent years, Paul became CEO of Pragmatic Informatics, an IT development firm with customers across North America and Europe, and then in 2016, founded Knalysis Technologies. Today, Paul is the President of Knalysis and sits on the Board of Directors of Canada House Wellness Group.

Richard Bennet, CTO

Richard holds a PhD in Computer Science from Edinburgh University.  His PhD studies included the application of machine learning and data analytics.

Richard co-founded a company to develop mesh networking technology for integration of legacy medical devices. Mobile Healthcare Technologies (MHN) was awarded a SMART award in the UK. Working with MHN as CTO, Richard developed and managed the application of neural networks to learn the relationship between moods and music for playlist-generation.

After moving to Canada in 2009, Richard worked on a variety of ventures before founding Pragmatic Informatics. Here, Richard has overseen a variety of large software projects, from the travel aggregation space to Holographic UX (Microsoft Hololens) to blockchain and drone applications. In 2016, he co-founded Knalysis Technologies where he applies his background in machine learning and data to identify the efficacy of medical marijuana health outcomes as the CTO of Knalysis Technologies.

Megan Rideout, COO

Megan’s career has always combined a passion for building deep relationships and the desire to find the right solution for a client through technology.  She has had the pleasure of working with an impressive list of clients across verticals including General Motors, Deloitte, Scotiabank, Starbucks, Suncor and the Canadian Automobile Association. Megan has management experience in large scale corporate and startup environments ranging from network solutions, travel, interactive technology, and loyalty marketing. 

In her role as a founding member of the Expedia Corporate Travel’s (now Egencia) Canadian operation, Megan helped clients understand how to leverage Expedia’s powerful technology to create and reinforce travel policies, achieving significant savings to enhance its bottom line.  Megan continued her exploration of driving behaviour with data when she stepped into the role of Director, Key Accounts at Bond Brand Loyalty (formerly Maritz Canada).  Managing the P&L for Scotiabank’s B2B and credit card loyalty programs and ultimately the operation of the SCENE LP business for Bond, Megan gained a deep knowledge of customer loyalty and engagement technology to increase the value exchange between program members and the brand.

Megan is now applying her expertise in client services, tech and data analysis as the COO of Knalysis Technologies, an innovator in the Canadian cannabis space.

Knalysis has big plans for 2018 and beyond.  Stay tuned for more exciting news.

About Knalysis Technologies:

Knalysis Technologies is part of the Canada House Wellness Group, a publicly-traded Canadian company with one of the largest networks of cannabis clinics in Canada.  It envisioned a need for health technology connecting every aspect of the medical marijuana field, and pioneered software to seamlessly link physicians, health providers, and patients.  Purpose-built in our own clinics, Knalysis’ suite of software has been battle-tested with thousands of patients for over four years; with its data helping in treating a broad range of ailments and symptoms.

Canada House Wellness Group Inc.

Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company’s goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit or

Cautionary Statement Regarding Forward‐Looking Information. Certain statements within this news release pertaining to the Company constitute “forward‐looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward‐looking statements”. Such “forward‐looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward‐looking statements include, but are not limited to, statements with respect to the anticipated effects of the financing, regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, competition and other risks affecting the Company in particular and the medical marijuana industry generally, including those set out in the Company’s public disclosure record. The Company assumes no responsibility to update or revise forward‐looking information to reflect new events or circumstances unless required by law.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.


Contact Data